Author:
Choi Myung-Sook,Lee Mi-Kyung,Jung Un Ju,Kim Hye-Jin,Do Geoyng-Min,Park Yong Bok,Jeon Seon-Min
Subject
Food Science,Biotechnology
Reference46 articles.
1. Phosphoinositol glycan derived mediators and insulin resistance. Prospects for diagnosis and therapy;Larner;J. Basic Clin. Physiol. Pharmacol.,1998
2. A model phosphatase 2C → phosphatase 1 activation cascade via dual control of inhibitor-1 (INH-1) and DARPP-32 dephosphorylation by two inositol glycan putative insulin mediators from beef liver;Huang;Biochem. Biophys. Res. Commun.,1999
3. Phosphoinositol-glycan-peptides from yeast potently induce metabolic insulin actions in isolated rat adipocytes, cardiomyocytes, and diaphragms;Müller;Endocrinology,1997
4. Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycaemia;Fonteles;Diabetologia,1996
5. Ostlund, R., Sherman, W., Pinitol and derivatives thereof for the treatment of metabolic disorders, US Patent No. 5550166, 1996.
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献